Fibroblasts and endothelial cells: The basic angiogenic unit

Angiogenesis: Insights from a Systematic Overview

Volumn , Issue , 2013, Pages 145-158

  Berthod, François ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892050049     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. Kannan RY, Salacinski HJ, Sales K, Butler P, Seifalian AM. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials. 2005;26(14): 1857-1875.
2. Berthod F, Germain L, Pouliot R, Auger F. How to achieve early vascularization of tissue-engineered skin substitutes. In: Sen CK, ed. Advances in Wound Care. Vol 1. New Rochelle, NY: Mary Ann Liebert, Inc.; 2010:445-450.
3. Young DM, Greulich KM, Weier HG. Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. J. Burn Care Rehabil. 1996;17:305-310.
4. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am. J. Transplant. 2005;5(5):1002-1010.
5. Norrby K. In vivo models of angiogenesis. J. Cell. Mol. Med. 2006;10(3):588-612.
6. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA, Davis GE. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 2001;114(Pt 15):2755-2773.
7. Nakatsu MN, Hughes CC. An optimized three-dimensional in vitro model for the analysis of angiogenesis. Methods Enzymol. 2008;443:65-82.
8. Donovan D, Brown NJ, Bishop ET, Lewis CE. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis. 2001;4(2): 113-121.
9. Santulli G, Basilicata MF, De Simone M, Del Giudice C, Anastasio A, Sorriento D, Saviano M, Del Gatto A, Trimarco B, Pedone C, Zaccaro L, Iaccarino G. Evaluation of the anti-angiogenic properties of the new selective alphaVbeta3 integrin antagonist RGDechiHCit. J Transl Med. 2011;9:7.
10. Kuo CH, Chen PK, Chang BI, Sung MC, Shi CS, Lee JS, Chang CF, Shi GY, Wu HL. The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen. Blood. 2012;119(5): 1302-1313.
11. Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G. CaMK4 Gene Deletion Induces Hypertension. Journal of the American Heart Association; 2012;1:e001081 doi:10.1161/JAHA.112.001081.
12. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146(6):873-887.
13. Gerwins P, Skoldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit. Rev. Oncol. Hematol. 2000;34(3):185-194.
14. Berthod F, Germain L, Tremblay N, Auger FA. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J. Cell. Physiol. 2006;207(2):491-498.
15. Kamio K, Sato T, Liu X, Sugiura H, Togo S, Kobayashi T, Kawasaki S, Wang X, Mao L, Ahn Y, Holz O, Magnussen H, Rennard SI. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1226-1232.
16. Orlandini M, Oliviero S. In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J. Biol. Chem. 2001;276(9):6576-6581.
17. Liu J, Rich CB, Buczek-Thomas JA, Nugent MA, Panchenko MP, Foster JA. Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2003;285(5):L1106-1115.
18. Blasi A, Martino C, Balducci L, Saldarelli M, Soleti A, Navone SE, Canzi L, Cristini S, Invernici G, Parati EA, Alessandri G. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in antiinflammatory and angiogenic potential. Vascular cell. 2011;3(1):5.
19. Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CC. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol. Biol. Cell. 2011;22(20):3791-3800.
20. Eming SA, Hubbell JA. Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp. Dermatol. 2011;20(7):605-613.
21. Belotti D, Foglieni C, Resovi A, Giavazzi R, Taraboletti G. Targeting angiogenesis with compounds from the extracellular matrix. Int. J. Biochem. Cell Biol. 2011;43(12): 1674-1685.
22. Liu H, Chen B, Lilly B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis. 2008;11(3):223-234.
23. Cavallaro U, Tenan M, Castelli V, Perilli A, Maggiano N, Van Meir EG, Montesano R, Soria MR, Pepper MS. Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis. J. Cell. Biochem. 2001;82(4):619-633.
24. Berthod F, Hayek D, Damour O, Collombel C. Collagen synthesis by fibroblasts cultured within a collagen sponge. Biomaterials. 1993;14:749-754.
25. Nimni M, Harkness R. Molecular structure and functions of collagen. In: Nimni M, ed. Collagen. Vol 1. Boca Raton: CRC Press; 1988:3-79.
26. Quaglino D, Fornieri C, Botti B, Davidson JM, Pasquali-Ronchetti I. Opposing effects of ascorbate on collagen and elastin deposition in the neonatal rat aorta. Eur. J. Cell Biol. 1991;54(1):18-26.
27. Michel M, L'Heureux N, Pouliot R, Xu W, Auger FA, Germain L. Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell. Dev. Biol. Anim. 1999;35(6):318-326.
28. Pouliot R, Larouche D, Auger FA, Juhasz J, Xu W, Li H, Germain L. Reconstructed human skin produced in vitro and grafted on athymic mice. Transplantation. 2002;73(11):1751-1757.
29. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 1998;12(1):47-56.
30. Proulx S, d'Arc Uwamaliya J, Carrier P, Deschambeault A, Audet C, Giasson CJ, Guerin SL, Auger FA, Germain L. Reconstruction of a human cornea by the selfassembly approach of tissue engineering using the three native cell types. Mol. vis. 2010;16:2192-2201.
31. Larouche D, Paquet C, Fradette J, Carrier P, Auger FA, Germain L. Regeneration of skin and cornea by tissue engineering. Methods Mol. Biol. 2009;482:233-256.
32. Rochon MH, Fradette J, Fortin V, Tomasetig F, Roberge CJ, Baker K, Berthod F, Auger FA, Germain L. Normal human epithelial cells regulate the size and morphology of tissue-engineered capillaries. Tissue Eng. Part A. 2010;16(5):1457-1468.
33. Gibot L, Galbraith T, Huot J, Auger FA. A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. Tissue Eng. Part A. 2010;16(10):3199-3206.
34. Berthod F, Auger FA. In vitro applications of skin substitutes for dermatological purposes. In: Rouabhia M, ed. Skin substitute production by tissue engineering: clinical and fundamental applications. Austin: Landes Bioscience; 1997:211-237.
35. Berthod F, Germain L, Guignard R, Lethias C, Garrone R, Damour O, van der Rest M, Auger FA. Differential expression of collagen XII and XIV in human skin and in reconstructed skin. J. Invest. Dermatol. 1997;108(5):737-742.
36. Black A, Berthod F, L'Heureux N, Germain L, Auger FA. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 1998;12:1331-1340.
37. Hudon V, Berthod F, Black AF, Damour O, Germain L, Auger FA. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br. J. Dermatol. 2003;148(6):1094-1104.
38. Tremblay PL, Berthod F, Germain L, Auger FA. In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. J. Pharmacol. Exp. Ther. 2005;315(2):510-516.
39. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005;97(6):512-523.
40. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature. 2008;456(7223):809-813.
41. Hall AP. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol. Pathol. 2006;34(6):763-775.
42. Bryan BA, D'Amore PA. Pericyte isolation and use in endothelial/pericyte coculture models. Methods Enzymol. 2008;443:315-331.
43. Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, Ravazzola M, Orci L. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J. Histochem. Cytochem. 1989;37(3):315-321.
44. Liu P, Zhang C, Chen J, Zhang R, Ren J, Huang Y, Zhu F, Li Z, Wu G. Combinational therapy of interferon-alpha and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma. J Immunother. 2011;34(3):320-326.
45. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev. Dyn. 2001;222(2):218-227.
46. Helmbold P, Wohlrab J, Marsch WC, Nayak RC. Human dermal pericytes express 3G5 ganglioside--a new approach for microvessel histology in the skin. J. Cutan. Pathol. 2001;28(4):206-210.
47. Gushi A, Tanaka M, Tsuyama S, Nagai T, Kanzaki T, Kanekura T, Matsuyama T. The 3G5 antigen is expressed in dermal mast cells but not pericytes. J. Cutan. Pathol. 2008;35(3):278-284.
48. Murfee WL, Rehorn MR, Peirce SM, Skalak TC. Perivascular cells along venules upregulate NG2 expression during microvascular remodeling. Microcirculation. 2006;13(3):261-273.
49. Berthod F, Symes J, Tremblay N, Medin JA, Auger FA. Spontaneous fibroblast-derived pericyte recruitment in a human tissue-engineered angiogenesis model in vitro. J. Cell. Physiol. 2012;227(5):2130-2137.
50. Shepro D, Morel NM. Pericyte physiology. FASEB J. 1993;7(11):1031-1038.
51. Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277(5323):242-245.
52. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-de Groot AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ. Res. 1997;80(4):444-451.
53. Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A. VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev. Dyn. 2004;230(1):23-33.
54. Lamagna C, Bergers G. The bone marrow constitutes a reservoir of pericyte progenitors. J. Leukoc. Biol. 2006;80(4):677-681.
55. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc. Res. 1996;32(4):687-698.
56. Stein J, Drenckhahn D, Nehls V. Development of pericyte-like cells during angiogenesis in quail chick chimeras as detected by combined Feulgen reaction and immunohistochemistry. Annals of anatomy = Anatomischer Anzeiger: official organ of the Anatomische Gesellschaft. 1996;178(2): 153-158.
57. Cai X, Lin Y, Friedrich CC, Neville C, Pomerantseva I, Sundback CA, Zhang Z, Vacanti JP, Hauschka PV, Grottkau BE. Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev. 2009;5(4):437-445.
58. Caplan AI. All MSCs are pericytes? Cell Stem Cell. 2008;3(3):229-230.
59. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B. Perivascular multipotent progenitor cells in human organs. Ann. N. Y. Acad. Sci. 2009;1176:118-123.
60. Crisan M, Deasy B, Gavina M, Zheng B, Huard J, Lazzari L, Peault B. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol. 2008;86:295-309.
61. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. Vascular pericytes express osteogenic potential in vitro and in vivo. J. Bone Miner. Res. 1998;13(5):828-838.